Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.02.2023 | Case report

Cytarabine/idarubicin

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Park S, et al. Laboratory Perspective of Concurrent Acute Myeloid Leukemia and COVID-19: a Case Report and Review of Literature. [Review]. Clinical Laboratory: Journal for Clinical Laboratories and Laboratories Related to Blood Transfusion 68: No. 11, Nov 2022. Available from: URL: http://doi.org/10.7754/Clin.Lab.2022.220144 Park S, et al. Laboratory Perspective of Concurrent Acute Myeloid Leukemia and COVID-19: a Case Report and Review of Literature. [Review]. Clinical Laboratory: Journal for Clinical Laboratories and Laboratories Related to Blood Transfusion 68: No. 11, Nov 2022. Available from: URL: http://​doi.​org/​10.​7754/​Clin.​Lab.​2022.​220144
Metadaten
Titel
Cytarabine/idarubicin
Lack of efficacy: case report
Publikationsdatum
01.02.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-33137-z

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Tozinameran

Case report

Adalimumab

Case report

Multiple drugs